Works matching IS 10870156 AND DT 2013 AND VI 31 AND IP 3
Results: 34
SBIR widens cash net.
- Published in:
- Nature Biotechnology, 2013, v. 31, n. 3, p. 186, doi. 10.1038/nbt0313-186a
- By:
- Publication type:
- Article
Efficient genome editing in zebrafish using a CRISPR-Cas system.
- Published in:
- Nature Biotechnology, 2013, v. 31, n. 3, p. 227, doi. 10.1038/nbt.2501
- By:
- Publication type:
- Article
Amgen fined $762 million.
- Published in:
- Nature Biotechnology, 2013, v. 31, n. 3, p. 182, doi. 10.1038/nbt0313-182
- By:
- Publication type:
- Article
People.
- Published in:
- Nature Biotechnology, 2013, v. 31, n. 3, p. 262, doi. 10.1038/nbt.2535
- Publication type:
- Article
Unfoldase-mediated protein translocation through an ?-hemolysin nanopore.
- Published in:
- Nature Biotechnology, 2013, v. 31, n. 3, p. 247, doi. 10.1038/nbt.2503
- By:
- Publication type:
- Article
Another blow for ALS.
- Published in:
- Nature Biotechnology, 2013, v. 31, n. 3, p. 185, doi. 10.1038/nbt0313-185
- By:
- Publication type:
- Article
Biotech bonanza hits UK.
- Published in:
- Nature Biotechnology, 2013, v. 31, n. 3, p. 183, doi. 10.1038/nbt0313-183
- By:
- Publication type:
- Article
Longitudinal thinking.
- Published in:
- Nature Biotechnology, 2013, v. 31, n. 3, p. 177, doi. 10.1038/nbt.2534
- Publication type:
- Article
Innovative startups 2012.
- Published in:
- Nature Biotechnology, 2013, v. 31, n. 3, p. 194, doi. 10.1038/nbt.2518
- By:
- Publication type:
- Article
Back on target.
- Published in:
- Nature Biotechnology, 2013, v. 31, n. 3, p. 191, doi. 10.1038/nbt.2520
- By:
- Publication type:
- Article
RNA guides genome engineering.
- Published in:
- Nature Biotechnology, 2013, v. 31, n. 3, p. 208, doi. 10.1038/nbt.2527
- By:
- Publication type:
- Article
RNA-guided editing of bacterial genomes using CRISPR-Cas systems.
- Published in:
- Nature Biotechnology, 2013, v. 31, n. 3, p. 233, doi. 10.1038/nbt.2508
- By:
- Publication type:
- Article
Wyss Institute to rise in Merck Serono shell.
- Published in:
- Nature Biotechnology, 2013, v. 31, n. 3, p. 188, doi. 10.1038/nbt0313-188b
- By:
- Publication type:
- Article
Water stress survivors.
- Published in:
- Nature Biotechnology, 2013, v. 31, n. 3, p. 188, doi. 10.1038/nbt0313-188a
- By:
- Publication type:
- Article
A library of TAL effector nucleases spanning the human genome.
- Published in:
- Nature Biotechnology, 2013, v. 31, n. 3, p. 251, doi. 10.1038/nbt.2517
- By:
- Publication type:
- Article
Orphazyme.
- Published in:
- Nature Biotechnology, 2013, v. 31, n. 3, p. 189, doi. 10.1038/nbt0313-189
- By:
- Publication type:
- Article
Drug pipeline: Q412.
- Published in:
- Nature Biotechnology, 2013, v. 31, n. 3, p. 190, doi. 10.1038/nbt.2525
- By:
- Publication type:
- Article
Antisense battles small molecule for slice of rare lipid disorder market.
- Published in:
- Nature Biotechnology, 2013, v. 31, n. 3, p. 179, doi. 10.1038/nbt0313-179
- By:
- Publication type:
- Article
Personalized, sequencing-based immune profiling spurs startups.
- Published in:
- Nature Biotechnology, 2013, v. 31, n. 3, p. 184, doi. 10.1038/nbt0313-184b
- By:
- Publication type:
- Article
FDA okays IT-powered trial.
- Published in:
- Nature Biotechnology, 2013, v. 31, n. 3, p. 184, doi. 10.1038/nbt0313-184a
- By:
- Publication type:
- Article
Blockbuster dreams for Pfizer's CDK inhibitor.
- Published in:
- Nature Biotechnology, 2013, v. 31, n. 3, p. 187, doi. 10.1038/nbt0313-187a
- By:
- Publication type:
- Article
Cardiac regenerative medicine 2.0.
- Published in:
- Nature Biotechnology, 2013, v. 31, n. 3, p. 209, doi. 10.1038/nbt.2524
- By:
- Publication type:
- Article
Drug-proof grapefruit.
- Published in:
- Nature Biotechnology, 2013, v. 31, n. 3, p. 186, doi. 10.1038/nbt0313-186b
- Publication type:
- Article
Scientific considerations in the review and approval of generic enoxaparin in the United States.
- Published in:
- Nature Biotechnology, 2013, v. 31, n. 3, p. 220, doi. 10.1038/nbt.2528
- By:
- Publication type:
- Article
Patent landscaping for life sciences innovation: toward consistent and transparent practices.
- Published in:
- Nature Biotechnology, 2013, v. 31, n. 3, p. 202, doi. 10.1038/nbt.2521
- By:
- Publication type:
- Article
Recent patent applications in oligonucelotide synthesis.
- Published in:
- Nature Biotechnology, 2013, v. 31, n. 3, p. 207, doi. 10.1038/nbt.2538
- Publication type:
- Article
Around the world in a month.
- Published in:
- Nature Biotechnology, 2013, v. 31, n. 3, p. 187, doi. 10.1038/nbt0313-187b
- Publication type:
- Article
Life sciences venture capital in emerging markets.
- Published in:
- Nature Biotechnology, 2013, v. 31, n. 3, p. 195, doi. 10.1038/nbt.2529
- By:
- Publication type:
- Article
Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples.
- Published in:
- Nature Biotechnology, 2013, v. 31, n. 3, p. 213, doi. 10.1038/nbt.2514
- By:
- Publication type:
- Article
Pay increases for nonfounder executives at private life sciences companies rebound.
- Published in:
- Nature Biotechnology, 2013, v. 31, n. 3, p. 259, doi. 10.1038/nbt.2526
- By:
- Publication type:
- Article
Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease.
- Published in:
- Nature Biotechnology, 2013, v. 31, n. 3, p. 230, doi. 10.1038/nbt.2507
- By:
- Publication type:
- Article
Draft genome sequence of chickpea (Cicer arietinum) provides a resource for trait improvement.
- Published in:
- Nature Biotechnology, 2013, v. 31, n. 3, p. 240, doi. 10.1038/nbt.2491
- By:
- Publication type:
- Article
Single-cell sequencing in its prime.
- Published in:
- Nature Biotechnology, 2013, v. 31, n. 3, p. 211, doi. 10.1038/nbt.2523
- By:
- Publication type:
- Article
Industry pursues co-stimulatory receptor immunomodulators to treat cancer.
- Published in:
- Nature Biotechnology, 2013, v. 31, n. 3, p. 181, doi. 10.1038/nbt0313-181
- By:
- Publication type:
- Article